One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature
doi : 10.1136/ard-2023-225185
Shift in perspective: autoimmunity protecting against rheumatoid arthritis
doi : 10.1136/ard-2023-225237
Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis
doi : 10.1136/ard-2023-225093
EPO promotes the progression of rheumatoid arthritis by inducing desialylation via increasing the expression of neuraminidase 3
doi : 10.1136/ard-2023-224852
Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis
doi : 10.1136/ard-2023-224878
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort
doi : 10.1136/ard-2023-224959
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial
doi : 10.1136/ard-2023-224699
Single-cell profiling reveals kidney CD163+ dendritic cell participation in human lupus nephritis
doi : 10.1136/ard-2023-224788
Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome
doi : 10.1136/ard-2023-224930
Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types
doi : 10.1136/ard-2023-225179
Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial
doi : 10.1136/ard-2023-224487
Prognostic model to predict the incidence of radiographic knee osteoarthritis
doi : 10.1136/ard-2023-225090
Associations of residential greenness with bone mineral density and osteoporosis: the modifying effect of genetic susceptibility
doi : 10.1136/ard-2023-224941
Validation of the definition of rheumatoid arthritis flare based on SDAI and CDAI in clinical practice in two French independent cohorts
doi : 10.1136/ard-2023-225272
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study
doi : 10.1136/ard-2023-225162
Correction: Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
